Evidence map›Paper›PMID 41339367›Full record

ArticleScientific reports2025

Foundation model based prediction of lung cancer survival using temporal changes in dual time point CT scans.

Jessica Petrochuk, Suraj Pai, John He, Fridolin Haugg, Yiwen Xu, David Christiani, Raymond Mak, Hugo Aerts

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jessica PetrochukDepartment of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Suraj PaiDepartment of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
John HeDepartment of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Fridolin HauggDepartment of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Yiwen XuBC Cancer, Kelowna, British Columbia, Canada.
David ChristianiDepartment of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Raymond MakDepartment of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. rmak@mgb.org.
Hugo AertsDepartment of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Funding

The Boston Lung Cancer Survival CohortU01CA209414 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI David C Christiani · 2017 to 2026
$12.2M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Quantitative Radiomics System Decoding the Tumor PhenotypeU24CA194354 · NCI · DANA-FARBER CANCER INST · PI AERTS, HUGO, QUACKENBUSH, JOHN · 2015 to 2019
$3.5M
NCI NIH HHS R35 CA197449NCI NIH HHS U01 CA209414NCI NIH HHS U24 CA194354NIH(NCI) 5U01CA209414NIH-USA U24CA194354
6 · The paper itself

Abstract

Lung cancer remains a significant cause of mortality, with non-small cell lung cancer (NSCLC) representing most cases. Currently, clinical data based models fall short in predicting survival while more advanced deep learning based image models require vast amounts of data and are often limited to predictions based on single time points. This study uses dual time point CT scans and features derived from a foundation model to predict survival. A dataset containing 102 NSCLC patients treated with radiation therapy was used, with each patient having both pre-treatment and post-treatment CT scans. A foundation model applied to the scans generated high-dimensional feature vectors and these vectors were then further summarized. Statistical analyses, including random forest and gradient boosted survival models, were then used to predict survival. The results demonstrated that temporal changes in feature vectors, specifically the Euclidean distance and element-wise subtracted feature vectors, can offer improved prediction of survival over single-time point features and clinical data.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsTomography, X-Ray ComputedAgedDeep LearningFemaleHumansMaleMiddle AgedPrognosisSurvival AnalysisTime Factors

Identifiers

PMID41339367
PMCPMC12675525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.